• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重正常却患上 2 型糖尿病的个体:个人脂肪阈值。

Normal weight individuals who develop type 2 diabetes: the personal fat threshold.

机构信息

*Magnetic Resonance Centre, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, U.K.

†Diabetes Trials Unit, University of Oxford, U.K.

出版信息

Clin Sci (Lond). 2015 Apr;128(7):405-10. doi: 10.1042/CS20140553.

DOI:10.1042/CS20140553
PMID:25515001
Abstract

Type 2 diabetes (T2DM) is frequently regarded as a disease of obesity and its occurrence in individuals of normal body mass index (BMI) is often regarded as indicating a non-obesity-related subtype. However, the evidence for such a distinct, common subtype is lacking. The United Kingdom Prospective Diabetes Study (UKPDS) cohort of people diagnosed with T2DM in the 1970s and 1980s had a median BMI of only 28 kg/m2. UKPDS data form the basis of current understanding of the condition even though one in three of those studied had a BMI of less than 25 kg/m2. BMI, though, is a population measure and not a rigid personal guide. Weight loss is considered de rigueur for treating obese diabetic individuals, but it is not usually considered for those deemed to have a normal BMI. Given the new evidence that early T2DM can be reversed to normal glucose tolerance by substantial weight loss, it is important to explain why non-overweight people respond to this intervention as well as obese individuals. We hypothesize that each individual has a personal fat threshold (PFT) which, if exceeded, makes likely the development of T2DM. Subsequent weight loss to take the individual below their level of susceptibility should allow return to normal glucose control. Crucially, the hypothesized PFT is independent of BMI. It allows both understanding of development of T2DM in the non-obese and remission of diabetes after substantial weight loss in people who remain obese by definition. To illustrate this concept, we present the distribution curve of BMI at diagnosis for the UKPDS cohort, together with a diagram explaining individual behaviour within the population. The concept of PFT is of practical benefit in explaining the onset of diabetes and its logical management to the non-obese majority of people with T2DM.

摘要

2 型糖尿病(T2DM)通常被认为是肥胖症的一种疾病,而在正常体重指数(BMI)的个体中发生 T2DM 通常被认为表明存在一种非肥胖相关的亚型。然而,缺乏这种明确、常见亚型的证据。20 世纪 70 年代和 80 年代被诊断出患有 T2DM 的英国前瞻性糖尿病研究(UKPDS)队列的人群的 BMI 中位数仅为 28kg/m2。尽管研究中有三分之一的人的 BMI 低于 25kg/m2,但 UKPDS 数据仍然是当前对该疾病理解的基础。然而,BMI 是一个群体指标,而不是个人的硬性指标。减肥被认为是治疗肥胖糖尿病患者的必要措施,但对于那些被认为 BMI 正常的患者通常不会考虑减肥。鉴于新的证据表明,早期 T2DM 可以通过大量体重减轻恢复正常血糖耐量,解释为什么非超重人群也像肥胖人群一样对这种干预有反应是很重要的。我们假设每个人都有一个个人脂肪阈值(PFT),如果超过这个阈值,就有可能发展为 T2DM。随后的体重减轻使个体低于其易感性水平,应该可以恢复正常的血糖控制。至关重要的是,假设的 PFT 与 BMI 无关。它既能解释非肥胖人群中 T2DM 的发生,也能解释肥胖人群在大量体重减轻后糖尿病的缓解,因为肥胖人群的定义就是肥胖。为了说明这一概念,我们展示了 UKPDS 队列的诊断时 BMI 分布曲线,并附有一个解释人群中个体行为的图表。PFT 概念对于向非肥胖的大多数 T2DM 患者解释糖尿病的发生及其逻辑管理具有实际意义。

相似文献

1
Normal weight individuals who develop type 2 diabetes: the personal fat threshold.体重正常却患上 2 型糖尿病的个体:个人脂肪阈值。
Clin Sci (Lond). 2015 Apr;128(7):405-10. doi: 10.1042/CS20140553.
2
Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.体脂质量分布。对非胰岛素依赖型糖尿病患者以及伴有或不伴有糖耐量受损的肥胖受试者的代谢和动脉粥样硬化参数的影响。体重减轻的影响。
Verh K Acad Geneeskd Belg. 1989;51(1):47-80.
3
Long-term beneficial effect of a 16-week very low calorie diet on pericardial fat in obese type 2 diabetes mellitus patients.16 周极低热量饮食对肥胖 2 型糖尿病患者心包脂肪的长期有益作用。
Obesity (Silver Spring). 2012 Aug;20(8):1572-6. doi: 10.1038/oby.2011.390. Epub 2012 Jan 26.
4
[Is there a role for surgery in the treatment of type 2 diabetes?].[手术在2型糖尿病治疗中是否有作用?]
Dtsch Med Wochenschr. 2014 Jan;139(5):207-12. doi: 10.1055/s-0033-1359931. Epub 2014 Jan 21.
5
Beta-cell function and mass in type 2 diabetes.2型糖尿病中的β细胞功能与数量
Dan Med Bull. 2009 Aug;56(3):153-64.
6
Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.血清视黄醇结合蛋白4在肥胖症或肥胖相关的2型糖尿病中并未升高,但在胃旁路术后体脂相应减少后会降低。
Clin Endocrinol (Oxf). 2008 Aug;69(2):208-15. doi: 10.1111/j.1365-2265.2007.03156.x. Epub 2007 Dec 10.
7
[Expression of omentin in adipose tissues in obese and type 2 diabetic patients].[肥胖和2型糖尿病患者脂肪组织中网膜素的表达]
Zhonghua Yi Xue Za Zhi. 2009 Feb 17;89(6):381-4.
8
Weight change and duration of overweight and obesity in the incidence of type 2 diabetes.体重变化以及超重和肥胖持续时间与2型糖尿病发病率的关系
Diabetes Care. 1999 Aug;22(8):1266-72. doi: 10.2337/diacare.22.8.1266.
9
Less fat reduction per unit weight loss in type 2 diabetic compared with nondiabetic obese individuals completing a very-low-calorie diet program.与非糖尿病肥胖个体相比,完成极低热量饮食计划的 2 型糖尿病个体每单位体重减轻的脂肪量减少。
Metabolism. 2012 Jun;61(6):873-82. doi: 10.1016/j.metabol.2011.10.017. Epub 2011 Dec 5.
10
The obesity paradox, weight loss, and coronary disease.肥胖悖论、体重减轻与冠心病。
Am J Med. 2009 Dec;122(12):1106-14. doi: 10.1016/j.amjmed.2009.06.006. Epub 2009 Aug 13.

引用本文的文献

1
Aetiology of type 2 diabetes: an experimental medicine odyssey.2型糖尿病的病因:一段实验医学的探索之旅。
Diabetologia. 2025 May 2. doi: 10.1007/s00125-025-06428-0.
2
Association of Anthropometric Parameters with Elevated Fasting Blood Sugar among Filipino Adults Aged 18-65 years in Highly Urbanized Cities in the Philippines.菲律宾高度城市化城市中18至65岁成年菲律宾人体型测量参数与空腹血糖升高的关联
Acta Med Philipp. 2025 Mar 31;59(4):125-138. doi: 10.47895/amp.v59i4.11290. eCollection 2025.
3
Nutrition Interventions for Remission of Type 2 Diabetes: Potential Role for Diabetes-Specific Nutrition Formulas.
用于2型糖尿病缓解的营养干预措施:糖尿病专用营养配方的潜在作用
Clin Diabetes. 2024 Oct 28;43(2):291-302. doi: 10.2337/cd24-0052. eCollection 2025 Spring.
4
CT-derived adipose tissue characteristics and TAVI all-cause mortality and complications: a systematic review.CT衍生的脂肪组织特征与经导管主动脉瓣植入术的全因死亡率及并发症:一项系统评价
Eur J Med Res. 2025 Apr 24;30(1):325. doi: 10.1186/s40001-025-02587-3.
5
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Impacts Long-Term Outcomes After Curative-Intent Surgery for Hepatocellular Carcinoma.代谢功能障碍相关脂肪性肝病(MASLD)对肝细胞癌根治性手术后的长期预后有影响。
Aliment Pharmacol Ther. 2025 Apr;61(8):1318-1332. doi: 10.1111/apt.70002. Epub 2025 Feb 18.
6
Contributions of Hepatic Insulin Resistance and Islet β-Cell Dysfunction to the Blood Glucose Spectrum in Newly Diagnosed Type 2 Diabetes Mellitus.肝胰岛素抵抗和胰岛β细胞功能障碍对新诊断2型糖尿病患者血糖谱的影响
Diabetes Metab J. 2025 Jul;49(4):883-892. doi: 10.4093/dmj.2024.0537. Epub 2025 Feb 13.
7
Adipocentric Strategy for the Treatment of Type 2 Diabetes Mellitus.以脂肪为中心的2型糖尿病治疗策略
J Clin Med. 2025 Jan 21;14(3):678. doi: 10.3390/jcm14030678.
8
The Twin Cycle Hypothesis of type 2 diabetes aetiology: From concept to national NHS programme.2型糖尿病病因的双循环假说:从概念到英国国家医疗服务体系项目
Exp Physiol. 2025 Jul;110(7):984-991. doi: 10.1113/EP092009. Epub 2025 Feb 3.
9
Lessons Learned From Epidemiology of Type 2 Diabetes in South Asians: Kelly West Award Lecture 2024.从南亚2型糖尿病流行病学中汲取的经验教训:2024年凯利·韦斯特奖讲座
Diabetes Care. 2025 Feb 1;48(2):153-163. doi: 10.2337/dci24-0046.
10
The Causal Role of Ectopic Fat Deposition in the Pathogenesis of Metabolic Syndrome.异位脂肪沉积在代谢综合征发病机制中的因果作用。
Int J Mol Sci. 2024 Dec 10;25(24):13238. doi: 10.3390/ijms252413238.